VKH
CRL icon

Virtu KCG Holdings’s Charles River Laboratories CRL Stock Holding History

Virtu KCG Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,351
Closed -$696K – 3447
2016
Q3 		$696K Buy
8,351
+2,118
+34% +$178K 0.02% 1046
2016
Q2 		$514K Buy
+6,233
New +$513K 0.01% 1343
2015
Q4 		– Sell
-9,898
Closed -$629K – 3537
2015
Q3 		$629K Sell
9,898
-6,494
-40% -$466K 0.01% 1299
2015
Q2 		$1.15M Buy
16,392
+13,486
+464% +$998K 0.02% 739
2015
Q1 		$230K Sell
2,906
-922
-24% -$68K ﹤0.01% 2228
2014
Q4 		$244K Buy
+3,828
New +$240K ﹤0.01% 2618
2014
Q3 		– Sell
-4,286
Closed -$229K – 3637
2014
Q2 		$229K Sell
4,286
-2,580
-38% -$142K ﹤0.01% 2893
2014
Q1 		$414K Buy
6,866
+2,715
+65% +$158K 0.01% 2167
2013
Q4 		$220K Sell
4,151
-5,868
-59% -$295K ﹤0.01% 3005
2013
Q3 		$463K Buy
+10,019
New +$460K 0.01% 2098

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Virtu KCG Holdings's CRL Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Charles River Laboratories (CRL) in Q4 2016, closing a stake of 8,351 shares — an estimated $696K sold.

Virtu KCG Holdings first reported a position in CRL in Q3 2013 and held it in 10 quarters. The position peaked at $1.15M in Q2 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Charles River Laboratories position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 8,351 Charles River Laboratories shares in Q4 2016, an estimated $696K.
  • Virtu KCG Holdings first reported a position in Charles River Laboratories in Q3 2013 and held it in 10 quarters.
  • Virtu KCG Holdings's Charles River Laboratories position peaked at $1.15M in Q2 2015.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.